Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[EX Q]: With a bumper crop of blacklegged ticks possible this season, researchers in a Lyme disease-plagued part of New York’s Hudson Valley are tackling tick problems across entire neighborhoods with fungal sprays and bait boxes. The $8.8 million, five-year project aims to find out if treating 24 neighborhoods in Dutchess County for ticks, also known as deer ticks, can significantly reduce cases of Lyme disease and other tick-borne illnesses. “We want to do a better job and actually remove the threat from the neighborhoods, from the places where people are actually exposed to infected ticks,” said Richard Ostfeld, a disease ecologist with the Cary Institute of Ecosystem Studies in Millbrook, about 70 miles (110 kilometers) north of New York City. Dutchess County is a patchwork of forests, rolling farmland and thick residential developments that has long been a hotbed of Lyme disease. Tick checks are a common end-of-day routine here, as are inspections for the red, target-shaped rashes associated with tick bites. People spray on tick repellents, treat their clothes with insecticide and even spray their yards. But Ostfeld notes that spraying individual lawns has not proved effective in fighting Lyme disease. So he’s scaling up from one backyard to many. The Tick Project involves more than 900 families in neighborhoods that consist of about 30 to 50 participants. Yards are being treated in the spring and early summer with a fungal spray that kills ticks. Researchers also are deploying bait boxes to attract rodents. An insecticide in the box kills any ticks on mice and chipmunks, two animals largely responsible for infecting ticks with the bacterium that causes Lyme disease. Researchers check in with families every two weeks in season to see whether anyone in the house, including cats and dogs, had ticks on them over the period. The Tick Project is funded mostly through a $5 million grant from the Steven & Alexandra Cohen Foundation, created by the hedge fund manager and his wife. Ostfeld said 2021 is set aside for data analysis, thought they will have some sense of early results within a year. Ostfeld would not divulge which neighborhoods are involved or who is participating, citing the need for privacy and of keeping good relations with participants. Edward Blundell, mayor of the village of Red Hook, mentioned during an interview that he had agreed to take part in the study. While he felt he could take personal steps to protect himself from Lyme disease, he would be satisfied if something comes out of the research. “Let’s let the scientists look at this and give them a mini-lab site here, so we felt our yard could be the mini-site,” Blundell said. Tick researchers say such area-wide studies are complex and difficult to do. They are costly. It can be hard to get all the needed permissions. And variabilities in tick densities over study areas can make the science challenging. Thomas Mather, director of the Tick Encounter Resource Center at the University of Rhode Island, said executing a well-designed study large enough to produce valid results is a “Holy Grail” of tick researchers. Phillip Baker, executive director of the American Lyme Disease Foundation, said the neighborhood approach sounded like a good one but noted that ticks are a resilient parasite. “Ticks have been around for a long, long time,” Baker said, “and there’s no real easy approach to get rid of them.”
[EX A]: Tick towns: Researchers target neighborhoods in Lyme effort.

[EX Q]: Both warnings are true. On September 18, 2006, the U.S. Food and Drug Administration expanded its warning about spinach, telling consumers not to eat any raw spinach, not just pre-packaged spinach as had initially been announced. The FDA also announced that it’s probe into the sources of spinach contaminated with a strain of E.coli bacterium had been expanded to other companies. On September 15, 2006, the FDA had announced that Natural Selection Foods of San Juan Bautista, California was recalling all of its products that contain spinach that have “best if used by” dates of August 17, 2006 through October 1, 2006 The FDA is continuing to investigate whether any other brands are involved. According to an FDA release, “Natural Selection Foods, LLC brands include: Natural Selection Foods, Pride of San Juan, Earthbound Farm, Bellissima, Dole, Rave Spinach, Emeril, Sysco, O Organic, Fresh Point, River Ranch, Superior, Nature’s Basket, Pro-Mark, Compliments, Trader Joe’s, Ready Pac, Jansal Valley, Cheney Brothers, Coastline, D’Arrigo Brothers, Green Harvest, Mann, Mills Family Farm, Pro*Act, Premium Fresh, Snoboy, The Farmer’s Market, Tanimura & Antle, President’s Choice, Cross Valley, and Riverside Farms. These products include spinach and any salad with spinach in a blend, both retail and food service products. Products that do not contain spinach are not part of this recall.” The FDA said that 109 cases of illness had been reported to the Centers for Disease Control including one death and 14 cases of what is called Hemolytic Uremic Syndrome (HUS), a form of kidney failure. States included in the warning include: California, Connecticut, Idaho, Indiana, Kentucky, Maine, Michigan, Minnesota, Nevada, New Mexico, New York, Ohio, Oregon, Pennsylvania, Tennessee, Utah, Virginia, Washington, Wisconsin, and Wyoming. The FDA said the affected products were also distributed to Canada and Mexico. The other story was focused on Minneapolis, Minnesota. The Dateline show aired in April, 2006. When more than 10 cases of sick people with similar symptoms showed up within three days in September, 2005, a public health investigation was launched. The Minnesota Department of Public Health speculated that the sicknesses were food-related. One of the investigators suspected E.coli because of the symptoms of abdominal cramps and severe, bloody diarrhea. The problem was that E.coli poisoning was more commonly associated with eating contaminated and improperly cooked meat. One of the foods that most of the sick people had eaten was salads made from bagged lettuce. When a public health warning was issued about the salads, one of the victims called investigators from his hospital room and said he still had a partially-eaten bag in his refrigerator. That lettuce was tested and became the first evidence that the E.coli had come from the pre-packaged salads. The odd thing was that the bacterium was found in the lettuce, not just on it. As a result of that 2005 outbreak, the Dole company issued a voluntary recall for the “American Blend” and “Classic Romaine” packaged salads. The U.S. Food and Drug Administration also issued a nationwide health alert in October, 2005, about the particular Dole salads implicated in the outbreak. According to Dateline, 26 people from three states got ill, some of them seriously. There were no known deaths and there have not been any repeats of the problem. Updated 9/18/06 Comments
[EX A]:  There are a couple of stories about this. One warning says that a documentary on Dateline TV showed that E.coli bacteria were found in pre-packaged bags of salad and that the Dole company has issued a recall on some bags. The other from September of 2006 says the Food and Drug Administration has issued an alert that a strain of E.coli bacterium has been found in several U.S. states and that pre-packaged bags of spinach are suspect.  

[EX Q]: “Bayer has not proposed paying $8 billion to settle all the U.S. Roundup cancer claims. Such a statement is pure fiction,” Feinberg said in an email on Friday. “Compensation has not even been discussed in the global mediation discussions.”  Bayer shares, which had shed some of their gains before Feinberg’s statement, retreated further and closed up 1.7% at 64.63 euros. Bayer, which acquired Roundup and other glyphosate-based weedkillers as part of its $63 billion takeover of Monsanto last year, declined comment on the initial Bloomberg news report and on Feinberg’s response. Bayer Chief Executive Werner Baumann last week said the company would consider settling with U.S. plaintiffs only on reasonable terms, and if it “achieves finality of the overall litigation”. He added at the time the group was “constructively engaging” in a court-ordered process with mediator Feinberg on the cases heard in federal court. Most of the pending cases, however, have been filed with U.S. state courts. Feinberg added that any efforts by Bayer toward a comprehensive settlement were tied in with the mediation proceedings overseen by him. “These are all part of the same mediation process.”   Bayer shares have lost more than a third of their value, or roughly 30 billion euros ($34 billion), since last August when a California jury in the first such lawsuit found Monsanto should have warned of the alleged cancer risks from Roundup. The German drugs and pesticides company has engaged in negotiations with plaintiffs’ lawyers, two sources familiar with the matter told Reuters. “The problem is, how do you get the plaintiffs to climb down from their very high expectations? None of the jury verdicts so far have been favorable for Bayer,” one of the sources said, adding that talks were focused on basic questions such as how to handle potential future claims. Bayer said on Friday that the next U.S. glyphosate lawsuit initially scheduled to be heard in St. Louis, Missouri, this month would be postponed to Jan. 27, 2020, and that a following St. Louis case slated for September had also been postponed. The German company may benefit from having cases heard in the city where Monsanto was headquartered and where Bayer  manages its global seeds business. But Missouri is also known for juries that often hit companies with huge damages. Bloomberg said the delays had been pursued by Bayer to allow for undisturbed settlement talks. The initial unfavorable court rulings in the first three glyphosate cases, heard in California, have at times dragged Bayer’s market value below what it paid for Monsanto, although the shares are now trading above that level. The company, which says regulators and extensive research have found glyphosate to be safe, has previously said it was banking on U.S. appeals courts to reverse or tone down three initial court rulings that have so far awarded tens of millions of dollars to each plaintiff. Bloomberg cited three sources familiar with the discussions as saying Bayer’s lawyers were seeking an accord to resolve all current and future cases. Talks over cases that have yet to be filed were particularly tricky, the report added. While Bayer has indicated it could pay $6-$8 billion, plaintiffs’ lawyers want more than $10 billion to drop their claims, the report said. An estimate of a $20 billion hit from the litigation has previously been reflected in the share price, while a likely litigation settlement liability was in the mid single-digit billion dollar range, Bank of America analysts said in note. They kept a “neutral” rating on the stock, citing uncertainty over Bayer’s fortunes in the appeals process - with the first appeals verdict expected by the end of the year - and whether a settlement could be achieved before that. The number of U.S. plaintiffs blaming Roundup and other glyphosate-based weedkillers for cancer had continued to rise by 5,000 to 18,400, Bayer said last week.
[EX A]:
Bayer mediator dismisses report of $8 billion Roundup settlement.